neostigmine
Ligand Summary
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
UNII: 3982TWQ96G
PubChem: 8246
PubChem: 4456
PubChem: 5824
Guide to Pharmacology: 8993
ChEMBL: CHEMBL54126
ChEMBL: CHEMBL211471
DrugCentral: 1897
LyCHI: 3Z543ANGP158
Target Activities
17 Activities
Items per page:
1 – 10 of 17
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||